Correlation Between Palantir Technologies and Clovis Oncology
Can any of the company-specific risk be diversified away by investing in both Palantir Technologies and Clovis Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Palantir Technologies and Clovis Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Palantir Technologies Class and Clovis Oncology, you can compare the effects of market volatilities on Palantir Technologies and Clovis Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Palantir Technologies with a short position of Clovis Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Palantir Technologies and Clovis Oncology.
Diversification Opportunities for Palantir Technologies and Clovis Oncology
-0.36 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Palantir and Clovis is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Palantir Technologies Class and Clovis Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clovis Oncology and Palantir Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Palantir Technologies Class are associated (or correlated) with Clovis Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clovis Oncology has no effect on the direction of Palantir Technologies i.e., Palantir Technologies and Clovis Oncology go up and down completely randomly.
Pair Corralation between Palantir Technologies and Clovis Oncology
Given the investment horizon of 90 days Palantir Technologies is expected to generate 1.96 times less return on investment than Clovis Oncology. But when comparing it to its historical volatility, Palantir Technologies Class is 5.32 times less risky than Clovis Oncology. It trades about 0.13 of its potential returns per unit of risk. Clovis Oncology is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 20.00 in Clovis Oncology on September 2, 2024 and sell it today you would lose (8.00) from holding Clovis Oncology or give up 40.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 8.06% |
| Values | Daily Returns |
Palantir Technologies Class vs. Clovis Oncology
Performance |
| Timeline |
| Palantir Technologies |
| Clovis Oncology |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Palantir Technologies and Clovis Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Palantir Technologies and Clovis Oncology
The main advantage of trading using opposite Palantir Technologies and Clovis Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Palantir Technologies position performs unexpectedly, Clovis Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clovis Oncology will offset losses from the drop in Clovis Oncology's long position.| Palantir Technologies vs. Palo Alto Networks | Palantir Technologies vs. Adobe Systems Incorporated | Palantir Technologies vs. Crowdstrike Holdings | Palantir Technologies vs. Block Inc |
| Clovis Oncology vs. Stepan Company | Clovis Oncology vs. Biglari Holdings | Clovis Oncology vs. Eastman Kodak Co | Clovis Oncology vs. Shake Shack |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |